[sandbox] K4D COVID-19 Resource Hub
Sort by:
Date tagged
Date published
-
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. | medRxiv preprints (not peer reviewed)
https://api.zotero.org/groups/2494380/items/TAVF2BHL?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 09/23/2020
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
https://api.zotero.org/groups/2494380/items/7PELS3CQ?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 09/23/2020
-
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
https://api.zotero.org/groups/2494380/items/DSXD6V9W?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 09/23/2020
-
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
https://api.zotero.org/groups/2494380/items/R98KP52Q?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 09/23/2020